Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Morbidity and mortality in patients with cardiovascular risk factors and obstructive sleep apnoea: results from the DIAST-CHF cohort.

Haarmann H, Koch J, Bonsch N, Mende M, Werhahn SM, Lüers C, Stahrenberg R, Edelmann F, Holzendorf V, von Haehling S, Pieske B, Andreas S, Lüthje L, Wachter R.

Respir Med. 2019 Jul - Aug;154:127-132. doi: 10.1016/j.rmed.2019.06.019. Epub 2019 Jun 21.

PMID:
31252205
2.

Vitamin D deficiency in patients with diastolic dysfunction or heart failure with preserved ejection fraction.

Nolte K, Herrmann-Lingen C, Platschek L, Holzendorf V, Pilz S, Tomaschitz A, Düngen HD, Angermann CE, Hasenfuß G, Pieske B, Wachter R, Edelmann F.

ESC Heart Fail. 2019 Apr;6(2):262-270. doi: 10.1002/ehf2.12413. Epub 2019 Feb 19.

3.

B-type natriuretic peptides for the prediction of cardiovascular events and mortality in patients living with HIV: Results from the HIV-HEART study.

Reinsch N, Streeck H, Holzendorf V, Schulze C, Neumann T, Brockmeyer NH, Kehrmann J, Schadendorf D, Esser S; HIV HEART Study Group.

Int J Cardiol. 2019 Apr 15;281:127-132. doi: 10.1016/j.ijcard.2019.01.066. Epub 2019 Jan 23.

PMID:
30711264
4.

Gut Microbiota in Human Immunodeficiency Virus-Infected Individuals Linked to Coronary Heart Disease.

Kehrmann J, Menzel J, Saeedghalati M, Obeid R, Schulze C, Holzendorf V, Farahpour F, Reinsch N, Klein-Hitpass L, Streeck H, Hoffmann D, Buer J, Esser S; HIV-HEART Study Group.

J Infect Dis. 2019 Jan 9;219(3):497-508. doi: 10.1093/infdis/jiy524.

PMID:
30202890
5.

Galectin-3 as a Predictor of Left Ventricular Reverse Remodeling in Recent-Onset Dilated Cardiomyopathy.

Karatolios K, Chatzis G, Holzendorf V, Störk S, Richter A, Binas D, Schieffer B, Pankuweit S.

Dis Markers. 2018 Jun 19;2018:2958219. doi: 10.1155/2018/2958219. eCollection 2018.

6.

Clinical predictors of outcome in patients with inflammatory dilated cardiomyopathy.

Karatolios K, Holzendorf V, Hatzis G, Tousoulis D, Richter A, Schieffer B, Pankuweit S.

PLoS One. 2017 Dec 21;12(12):e0188491. doi: 10.1371/journal.pone.0188491. eCollection 2017.

7.

Prolongation of the QTc interval in HIV-infected individuals compared to the general population.

Reinsch N, Arendt M, Geisel MH, Schulze C, Holzendorf V, Warnke A, Neumann T, Brockmeyer NH, Schadendorf D, Eisele L, Erbel R, Moebus S, Jöckel KH, Esser S; HIV HEART Study Group and the Heinz Nixdorf Recall Investigative Group.

Infection. 2017 Oct;45(5):659-667. doi: 10.1007/s15010-017-1053-9. Epub 2017 Aug 3.

PMID:
28776165
8.

Ghrelin and hormonal markers under exercise training in patients with heart failure with preserved ejection fraction: results from the Ex-DHF pilot study.

Trippel TD, Holzendorf V, Halle M, Gelbrich G, Nolte K, Duvinage A, Schwarz S, Rutscher T, Wiora J, Wachter R, Herrmann-Lingen C, Duengen HD, Hasenfuß G, Pieske B, Edelmann F.

ESC Heart Fail. 2017 Feb;4(1):56-65. doi: 10.1002/ehf2.12109. Epub 2016 Aug 31.

9.

Long-term outcome and predictors of outcome in patients with non-ischemic dilated cardiomyopathy.

Karatolios K, Holzendorf V, Richter A, Schieffer B, Pankuweit S; Competence Network Heart Failure Germany.

Int J Cardiol. 2016 Oct 1;220:608-12. doi: 10.1016/j.ijcard.2016.06.167. Epub 2016 Jun 26.

PMID:
27390998
10.

The LIFE-Adult-Study: objectives and design of a population-based cohort study with 10,000 deeply phenotyped adults in Germany.

Loeffler M, Engel C, Ahnert P, Alfermann D, Arelin K, Baber R, Beutner F, Binder H, Brähler E, Burkhardt R, Ceglarek U, Enzenbach C, Fuchs M, Glaesmer H, Girlich F, Hagendorff A, Häntzsch M, Hegerl U, Henger S, Hensch T, Hinz A, Holzendorf V, Husser D, Kersting A, Kiel A, Kirsten T, Kratzsch J, Krohn K, Luck T, Melzer S, Netto J, Nüchter M, Raschpichler M, Rauscher FG, Riedel-Heller SG, Sander C, Scholz M, Schönknecht P, Schroeter ML, Simon JC, Speer R, Stäker J, Stein R, Stöbel-Richter Y, Stumvoll M, Tarnok A, Teren A, Teupser D, Then FS, Tönjes A, Treudler R, Villringer A, Weissgerber A, Wiedemann P, Zachariae S, Wirkner K, Thiery J.

BMC Public Health. 2015 Jul 22;15:691. doi: 10.1186/s12889-015-1983-z.

11.

Galectin-3 in patients with heart failure with preserved ejection fraction: results from the Aldo-DHF trial.

Edelmann F, Holzendorf V, Wachter R, Nolte K, Schmidt AG, Kraigher-Krainer E, Duvinage A, Unkelbach I, Düngen HD, Tschöpe C, Herrmann-Lingen C, Halle M, Hasenfuss G, Gelbrich G, Stough WG, Pieske BM.

Eur J Heart Fail. 2015 Feb;17(2):214-23. doi: 10.1002/ejhf.203. Epub 2014 Nov 24.

12.

Rates of cardiovascular events and deaths are associated with advanced stages of HIV-infection: results of the HIV HEART study 7, 5 year follow-up.

Esser S, Eisele L, Schwarz B, Schulze C, Holzendorf V, Brockmeyer NH, Hower M, Kwirant F, Rudolph R, Neumann T, Reinsch N.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19542. doi: 10.7448/IAS.17.4.19542. eCollection 2014.

13.

Feasibility of VECOPA, a dose-intensive chemotherapy regimen for children and adolescents with intermediate and advanced stage Hodgkin lymphoma: results of the GPOH-HD-2002/VECOPA pilot trial.

Mauz-Körholz C, Hasenclever D, Holzendorf V, Bernstädt M, Jürgens H, Burdach S, Eggert A, Berthold F, Müller HL, Frühwald MC, Klingebiel T, Metzler M, Körholz D.

Leuk Lymphoma. 2015 May;56(5):1308-14. doi: 10.3109/10428194.2014.961011. Epub 2014 Oct 9.

PMID:
25204374
14.

Impact of obstructive sleep apnoea on diastolic function.

Wachter R, Lüthje L, Klemmstein D, Lüers C, Stahrenberg R, Edelmann F, Holzendorf V, Hasenfuß G, Andreas S, Pieske B.

Eur Respir J. 2013 Feb;41(2):376-83. doi: 10.1183/09031936.00218211. Epub 2012 Jul 12.

Supplemental Content

Loading ...
Support Center